Apyx Medical Corporation (APYX) vs Sera Prognostics, Inc. (SERA)
- Apyx Medical Corporation APYX 2.55 −0.39%
- Sera Prognostics, Inc. SERA 2.06 +1.48%
Apyx Medical Corporation and Sera Prognostics, Inc. are both Medical Devices companies. Apyx Medical Corporation is the larger, with a market value of $107.8M against $80.1M — 1.3× the size. Apyx Medical Corporation grew revenue faster over the last twelve months: 25.6% against −35.2%. Apyx Medical Corporation has the higher net margin (−14.8% vs −47,475.7%) and the higher return on invested capital (−11.8% vs −180.2%). Across the 18 metrics below, Apyx Medical Corporation leads on 14 and Sera Prognostics, Inc. on 4.
Valuation
Profitability
| Metric | APYX | SERA | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.50% | (150.00%) | 56.01% |
| Operating margin | (6.06%) | (53,282.86%) | (15.03%) |
| Net margin | (14.78%) | (47,475.71%) | (20.40%) |
| Free cash flow margin | (18.91%) | (40,760.00%) | (7.24%) |
| Return on equity | (93.11%) | (45.03%) | (15.32%) |
| Return on assets | (14.48%) | (33.47%) | (19.72%) |
| Return on invested capital | (11.76%) | (180.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack